WHAT IS POLYCYSTIC OVARIAN SYNDROME?
Polycystic ovary syndrome (PCOS) is a hormonal disorder common among women of reproductive age. Women with PCOS may have infrequent or prolonged menstrual periods or excess male hormone (androgen) levels. The ovaries may develop numerous small collections of fluid (follicles) and fail to regularly release eggs.
WHY NAPRO TECHNOLOGY?
Polycystic ovaries are present in about 14 percent of healthy women. Full-blown polycystic ovarian disease, or PCOD, afflicts approximately 6 percent of women. Women who have PCOD have ovaries that function abnormally and have irregular ovulation. Many women are offered birth control pills for PCOS. Napro treatments do a better job. NaPro Technology is natural and gets to the root of the problem. NaPro Technology aids women and doctors in identifying and treating polycystic ovarian disease, or PCOD. Napro Technology uses a woman’s Creighton Model charts, which record various biological markers of her fertility and menstrual cycles. NaPro Technology uses women’s Creighton model charts as the key for diagnosing and treating PCOD. The information from the charts shows the abnormalities in a woman’s system and cycle. It then seeks to establish normal hormone levels by using surgery to reduce the size of the ovary.
NaProTechnology combines this surgery, called an ovarian wedge resection, with techniques that prevent scar tissue (called pelvic adhesions) with hormone management to cure the disease.
Using Creighton model charts, if polycystic ovaries are found, surgery can correct and treat polycystic ovaries which can contribute to infertility thereby improving the woman’s chance of conception.